Table 2. Descriptive and bivariate analysis of the treatment received according to in-hospital death in the study sample.
| Variables | n | % | In-hospital death | ||
|---|---|---|---|---|---|
| Survivor | Non-survivor | P value | |||
| n=196
(39.8%) |
n=297
(60.2%) |
||||
| Received antibiotic therapy | 0.686 | ||||
| No | 6 | 1.2 | 3 (50.0) | 3 (50.0) | |
| Yes | 487 | 98.8 | 193 (39.6) | 294 (60.4) | |
| Types of antibiotic therapy | 0.919 | ||||
| Azithromycin+ Cephalosporins | 381 | 78.2 | 151 (39.6) | 230 (60.4) | |
| Azithromycin | 45 | 9.3 | 20 (44.4) | 25 (55.6) | |
| Cephalosporins | 26 | 5.3 | 10 (38.5) | 16 (61.5) | |
| Azithromycin + Carbapenems | 23 | 4.7 | 7 (30.4) | 16 (69.6) | |
| Carbapenems | 6 | 1.2 | 3 (50.0) | 3 (50.0) | |
| Azithromycin + others | 4 | 0.8 | 1 (25.0) | 3 (75.0) | |
| Others | 2 | 0.4 | 1 (50.0) | 1 (50.0) | |
| Received corticosteroids | 0.971 | ||||
| No | 169 | 34.3 | 67 (39.6) | 102 (60.4) | |
| Yes | 324 | 65.7 | 129 (39.8) | 195 (60.2) | |
| Type of corticosteroids | <0.001 | ||||
| Methylprednisolone | 210 | 64.8 | 72 (34.3) | 138 (65.7) | |
| Dexamethasone | 88 | 27.2 | 48 (54.6) | 40 (45.4) | |
| Hydrocortisone | 21 | 6.5 | 4 (19.1) | 17 (80.9) | |
| Prednisone | 5 | 1.5 | 5 (100.0) | 0 (0.0) | |
| Received hydroxychloroquine | 0.554 | ||||
| No | 115 | 23.3 | 43 (37.4) | 72 (62.6) | |
| Yes | 378 | 76.7 | 153 (40.5) | 225 (59.5) | |
| Received ivermectin | 0.283 | ||||
| No | 365 | 74.0 | 140 (38.4) | 225 (61.6) | |
| Yes | 128 | 26.0 | 56 (43.8) | 72 (56.2) | |
| Received enoxaparin | <0.001 | ||||
| No | 102 | 20.7 | 55 (53.9) | 47 (46.1) | |
| Yes | 391 | 79.3 | 141 (36.1) | 250 (63.9) | |
| Received Lopinavir/Ritonavir | 0.283 | ||||
| No | 367 | 74.4 | 151 (41.1) | 216 (58.9) | |
| Yes | 126 | 25.6 | 45 (35.7) | 81 (64.3) | |